Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
15.10 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 11.09 - 17.765 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 15.10 | USD |
Catalyst Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.78B | 117.86M | - | 398.2M | 71.41M | 0.61 | 24.92 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.22 | 16.25 | 14.93 | 15.28 | 2,443,446 | -0.12 | -0.79% |
1 Month | 15.97 | 16.665 | 14.93 | 15.46 | 1,374,591 | -0.87 | -5.45% |
3 Months | 14.45 | 17.495 | 13.1161 | 15.30 | 1,368,407 | 0.65 | 4.50% |
6 Months | 12.74 | 17.495 | 11.89 | 14.73 | 1,414,229 | 2.36 | 18.52% |
1 Year | 16.43 | 17.765 | 11.09 | 13.99 | 1,487,244 | -1.33 | -8.09% |
3 Years | 4.62 | 22.11 | 4.43 | 12.37 | 1,617,140 | 10.48 | 226.84% |
5 Years | 5.44 | 22.11 | 2.235 | 8.66 | 1,769,348 | 9.66 | 177.57% |
Catalyst Pharmaceuticals Description
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. |